EriVan Bio

EriVan Bio is a pre-clinical stage biotechnology company specializing in the development of exosome-based delivery systems for therapeutic payloads. The company leverages its proprietary platform to engineer exosomes that can precisely deliver RNA, proteins, and small molecules to targeted cells, aiming to overcome the limitations of traditional delivery vehicles like lipid nanoparticles. Their research primarily focuses on applications in oncology and infectious diseases, seeking to enhance the efficacy and safety of genetic medicines. Based in Lexington, Kentucky, EriVan Bio is advancing a pipeline of next-generation biologics designed for high-precision medicine. The company's technology emphasizes scalable manufacturing and improved biodistribution for complex therapeutic cargos.